Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis (Q21261905)

22 June 2017

Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis (English)

1 reference

22 June 2017

5

Stefan Zeuzem

Stefan

Zeuzem

1 reference

22 June 2017

6

Christoph Sarrazin

Christoph

Sarrazin

1 reference

18 August 2022

Mireen Friedrich-Rust

series ordinal

1

object named as

Mireen Friedrich-Rust

author given names

Mireen

author last names

Friedrich-Rust

1 reference

22 June 2017

William Rosenberg

2

William

Rosenberg

1 reference

22 June 2017

Julie Parkes

series ordinal

3

author given names

Julie

author last names

Parkes

1 reference

22 June 2017

Eva Herrmann

series ordinal

4

author given names

Eva

author last names

Herrmann

1 reference

22 June 2017

language of work or name

English

0 references

publication date

9 September 2010

1 reference

22 June 2017

1 reference

22 June 2017

10

1 reference

22 June 2017

1

0 references

page(s)

103

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-230x-10-103

22 June 2017

0 references

cites work

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

FibroTest-ActiTest as a non-invasive marker of liver fibrosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Serum markers detect the presence of liver fibrosis: a cohort study.

27 September 2017

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-103

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-103

A novel panel of blood markers to assess the degree of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-103

Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-103

Exceeding the limits of liver histology markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-103

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-103

Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-103

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-103

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-10-103

Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Sampling variability of liver fibrosis in chronic hepatitis C.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2944336

Pain experienced during percutaneous liver biopsy

29 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20828377

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20828377

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-230X-10-103

1 reference

OpenCitations bibliographic resource ID

22 June 2017

782716

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference